These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 37236580)

  • 1. Environmental melamine exposure and adverse kidney outcomes in patients with type 2 diabetes mellitus.
    Tsai YC; Wu CF; Hung WW; Yu PS; Liu CC; Hsieh TJ; Chen CC; Li SS; Chen JJ; Chiu YW; Hwang SJ; Wu MT
    Environ Pollut; 2023 Aug; 331(Pt 1):121883. PubMed ID: 37236580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Melamine Levels and Progression of CKD.
    Tsai YC; Wu CF; Liu CC; Hsieh TJ; Lin YT; Chiu YW; Hwang SJ; Chen HC; Wu MT
    Clin J Am Soc Nephrol; 2019 Aug; 14(8):1133-1141. PubMed ID: 31337620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus.
    Yu PS; Wu PH; Hung WW; Lin MY; Zhen YY; Hung WC; Chang JM; Tsai JR; Chiu YW; Hwang SJ; Tsai YC
    J Clin Endocrinol Metab; 2024 Jul; 109(8):2097-2105. PubMed ID: 38267025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of melamine and cyanuric acid exposure with markers of kidney function in adults: Results from NHANES 2003-2004.
    Guo J; Wu C; Zhang J; Chang X; Zhang Y; Cao Y; Zhou Z
    Environ Int; 2020 Aug; 141():105815. PubMed ID: 32480140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melamine exposure threshold in early chronic kidney disease patients - A benchmark dose approach.
    Chen CC; Tsai YC; Wang YH; Wu CF; Chiu YW; Hwang SJ; Liu CC; Hsieh TJ; Wu MT
    Environ Int; 2021 Nov; 156():106652. PubMed ID: 34034116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the initial decline in estimated glomerular filtration rate on the risk of new-onset atrial fibrillation and adverse cardiovascular and renal events in patients with type 2 diabetes treated with sodium-glucose co-transporter-2 inhibitors.
    Chan YH; Chen SW; Chao TF; Kao YW; Huang CY; Chu PH
    Diabetes Obes Metab; 2021 Sep; 23(9):2077-2089. PubMed ID: 34047459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease.
    Gregorich M; Kammer M; Heinzel A; Böger C; Eckardt KU; Heerspink HL; Jung B; Mayer G; Meiselbach H; Schmid M; Schultheiss UT; Heinze G; Oberbauer R;
    JAMA Netw Open; 2023 Apr; 6(4):e231870. PubMed ID: 37017968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of bariatric surgery on estimated glomerular filtration rate in patients with type 2 diabetes: a retrospective cohort study.
    Mirajkar N; Bellary S; Ahmed M; Singhal R; Daskalakis M; Tahrani AA
    Surg Obes Relat Dis; 2016 Dec; 12(10):1883-1889. PubMed ID: 27516220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of plasma ceramide with decline in kidney function in patients with type 2 diabetes.
    Gurung RL; M Y; Tham WK; Liu S; Zheng H; Lee J; Ang K; Wenk M; Subramaniam T; Sum CF; Torta F; Liu JJ; Lim SC
    J Lipid Res; 2024 Jun; 65(6):100552. PubMed ID: 38704028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes.
    Oshima M; Toyama T; Hara A; Shimizu M; Kitajima S; Iwata Y; Sakai N; Furuichi K; Haneda M; Babazono T; Yokoyama H; Iseki K; Araki SI; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Makino H; Wada T
    BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 34193460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
    Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.
    Shurraw S; Hemmelgarn B; Lin M; Majumdar SR; Klarenbach S; Manns B; Bello A; James M; Turin TC; Tonelli M;
    Arch Intern Med; 2011 Nov; 171(21):1920-7. PubMed ID: 22123800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.
    Zoppini G; Targher G; Chonchol M; Ortalda V; Negri C; Stoico V; Bonora E
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):401-8. PubMed ID: 22282481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular filtration rate change and outcomes in type 2 diabetes.
    Caplan EO; Sheer R; Schmedt N; Evers T; Cockrell M; Tindal M; Pasquale MK; Kovesdy CP
    Am J Manag Care; 2021 May; 27(8 Suppl):S160-S167. PubMed ID: 34019358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA
    Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; Broedl UC; Woerle HJ; George JT; von Eynatten M; McGuire DK;
    Cardiovasc Diabetol; 2018 Mar; 17(1):39. PubMed ID: 29540217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between two common environmental toxicants (phthalates and melamine) and urinary markers of renal injury in the third trimester of pregnant women: The Taiwan Maternal and Infant Cohort Study (TMICS).
    Tsai HJ; Kuo FC; Wu CF; Sun CW; Hsieh CJ; Wang SL; Chen ML; Hsieh HM; Chuang YS; Wu MT
    Chemosphere; 2021 Jun; 272():129925. PubMed ID: 35534976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric surgery is associated with improvement in kidney outcomes.
    Chang AR; Chen Y; Still C; Wood GC; Kirchner HL; Lewis M; Kramer H; Hartle JE; Carey D; Appel LJ; Grams ME
    Kidney Int; 2016 Jul; 90(1):164-71. PubMed ID: 27181999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.